1.

[Article] Ledlie, Shaleesa and Garg, Ria and Leece, Pamela and Kolla, Gillian and Hyshka, Elaine and Tadrous, Mina and Gomes, Tara (2026) Trends in fentanyl-containing drug samples seized by law enforcement agencies across Canada. Addiction, Early online. https://doi.org/10.1111/add.70314

2.

[FactSheet] HRB National Drugs Library. (2026) Factsheet: New psychoactive substances (NPS) - the Irish situation 2026. Dublin: HRB National Drugs Library.

3.

[Report] Public Health Scotland. (2026) Rapid Action Drug Alerts and Response (RADAR) quarterly reports 2026. Edinburgh: Public Health Scotland.

4.

[Article] Rock, Kirsten L and Treble, Ric and Copeland, Caroline S (2026) Legislating novel psychoactive substances: lessons from 15 years of UK mortality data (2007-2022). Frontiers in Pharmacology, 16. https://doi.org/10.3389/fphar.2025.1708335

5.

[Article] Nielsen, Suzanne and Silva, João Pedro and Jones, Jermaine D and Krotulski, Alex and Poovendran, Dilkushi and Muzangizi, Deusdedit and Forte, Gilles and White, Jason and Comer, Sandra D (2026) Behavioural effects and naloxone effectiveness with new synthetic opioids. Drug and Alcohol Review, 45, (1). https://doi.org/10.1111/dar.70040

6.

[Report] Forensic Science Ireland. (2025) Forensic Science Ireland annual report 2024. Dublin: Forensic Science Ireland.

7.

[Article] Shiwach, Rajinder and Le Foll, Bernard and Alho, Hannu and Dunn, Kelly E and Strafford, Stephanie and Zhao, Yue and Dobbins, Robert L (2025) Comparison of extended-release buprenorphine doses for treating high-risk opioid use: a randomized clinical trial. JAMA Network Open, 8, (12). 10.1001/jamanetworkopen.2025.48043

8.

[Report] Advisory Council on the Misuse of Drugs. (2025) Advisory Council on the Misuse of Drugs annual report (January 2023 to December 2025 consolidated). London: Advisory Council on the Misuse of Drugs.

9.

[Article] Wilkinson, Emma (2025) The rise of nitazenes: what pharmacists need to know. The Pharmacist,

10.

[News] [Irish Times] , Lally, Conor Drug-driving surging due to ‘really concerning’ rates of cocaine use. (12 Nov 2025)

11.

[Article] Chen, Shuoqi and Mais, David and Copeland, Caroline S (2025) Comparison of Office for National Statistics (ONS) and National Programme on Substance Use Mortality (NPSUM) data suggests that opioid-related deaths in England & Wales have been systematically underestimated. International Journal of Drug Policy, 145. https://doi.org/10.1016/j.drugpo.2025.104976

12.

[Report] House of Commons Justice Committee. (2025) Tackling the drugs crisis in our prisons. London: House of Commons.

13.

[Report] Ireland. Office of the Inspector of Prisons. (2025) Office of the Inspector of Prisons annual report 2024. Dublin: Office of the Inspector of Prisons.

14.

[Report] United Nations Office on Drugs and Crime. (2025) Afghanistan opium survey 2025. Vienna: UNODC.

15.

[Report] Man, Nicola and Chrzanowska, Agata and Sutherland, Rachel and Sadaphale, Vandit and Barratt, Monica J and Bruno, Raimondo and Peacock, Amy (2025) Availability of nitazenes for purchase in Australia and internationally via cryptomarkets, September 2021 - August 2025. UNSW Sydney: National Drug and Alcohol Research Centre.

16.

[Report] Public Health Scotland. (2025) Rapid Action Drug Alerts and Response (RADAR) quarterly reports 2025. Edinburgh: Public Health Scotland.

17.

[Article] Shiwach, Rajinder and Le Foll, Bernard and Alho, Hannu and Dunn, Kelly E and Strafford, Stephanie and Zhao, Yue and Dobbins, Robert L (2025) Rapid vs standard induction to injectable extended-release buprenorphine: a randomized clinical trial. JAMA Network Open, 8, (10). https://doi.org/10.1001/jamanetworkopen.2025.37319

18.

[News] [Irish Times] , Kerrigan, Cathleen Naloxone: Why is this life-saving medication for suspected opioid overdoses not available over the counter? (16 Sep 2025)

19.

[Article] McNicholas, Ruairi and Sweeney, Nicola and Fenton, Fiona and Keenan, Eamon (2025) Enhancing naloxone provision in patients with comorbid mental illness and opioid use disorder amidst the rise of nitazenes in Ireland. Irish Journal of Psychological Medicine, Early online. pp. 1-2. https://doi.org/10.1017/ipm.2025.10102

20.

[Report] National Records of Scotland. (2025) Drug-related deaths in Scotland, 2024. Edinburgh: National Records of Scotland.

21.

[Audio] Society for the Study of Addiction. (2025) Addiction audio. Season 3, 2025. London: Society for the Study of Addiction.

22.

[News] Public Health Scotland. Public health alert for action: Nitazene-type drugs in Scotland. (12 Aug 2025)

23.

[Article] Marland, Victoria and Nisbet, Lorna and Nic Daéid, Niamh (2025) Evaluation of nitazene immunoassay test strips for rapid in-situ detection of nitazene and nitazene analogs in illicit drug samples. Harm Reduction Journal, 22. https://doi.org/10.1186/s12954-025-01287-9

24.

[Article] Trullols, Maite and Ruiz de Porras, Vicenç (2025) Opioid use in cancer pain management: navigating the line between relief and addiction. International Journal of Molecular Sciences, 26, (15). https://doi.org/10.3390/ijms26157459

25.

[Article] Piatkowski, Timothy and Kill, Emma and Reeve, Steph (2025) ‘The gear could be cut with fentanyl which is starting to happen more in Australia’: exploring overdose survivors’ perspectives on toxic supply and safe consumption. Drugs: Education Prevention and Policy, 32, (1), pp. 42-50. https://doi.org/10.1080/09687637.2024.2392520

26.

[Dail Debates] [Oireachtas] Dáil Éireann debate. Question 2811 and 2812 – Misuse of drugs [fentanyl] [42191/25, 42192/25]. (29 Jul 2025)

27.

[Article] Duddy, Claire (2025) What are synthetic drugs? House of Commons Library Insight,

28.

[Webpage] Center for Forensic Science Research and Education. (2025) CSFRE new psychoactive substances (NPS). Scope recommendations. URL: https://www.cfsre.org/nps-discovery/scope-recommen...

29.

[News] [UNODC] UNODC: CND decision on international control of four nitazenes enters into force. (13 Jun 2025)

30.

[Report] European Union Drugs Agency. (2025) Assessing the threat posed by the increased availability, use and harms of highly potent synthetic opioids in the Baltic region. Lisbon: EUDA.

31.

[Report] European Union Drugs Agency. (2025) Drug supply, production and precursors – the current situation in Europe (European Drug Report 2025). Lisbon: EUDA.

32.

[Report] European Union Drugs Agency. (2025) Drug-induced deaths – the current situation in Europe (European Drug Report 2025). Lisbon: EUDA.

33.

[Report] European Union Drugs Agency. (2025) Harm reduction – the current situation in Europe (European Drug Report 2025). Lisbon: EUDA.

34.

[Report] European Union Drugs Agency. (2025) Heroin and other opioids – the current situation in Europe (European Drug Report 2025). Lisbon: EUDA.

35.

[Report] European Union Drugs Agency. (2025) New psychoactive substances – the current situation in Europe (European Drug Report 2025). Lisbon: EUDA.

36.

[Report] European Union Drugs Agency. (2025) Understanding Europe’s drug situation in 2024 – key developments (European Drug Report 2025). Lisbon: EUDA.

37.

[FactSheet] National Drug and Alcohol Research Centre. (2025) NDARC fact sheet: nitazenes. Sydney: National Drug and Alcohol Research Centre.

38.

[Article] Sandhu, Kanwarpreet Singh and Kumar, Siddarth and Garg, Keshav and Aggarwal, Kanishk and Tiwwary, Mayank and Perry, Griffin and Bansal, Vasu and Jain, Rohit (2025) The xylazine-fentanyl nexus: a public health emergency. SAGE Open Medicine, 13. https://doi.org/10.1177/20503121251348068

39.

[Article] Stangeland, Marcus and Dale, Ola and Skulberg, Arne Kristian (2025) Nitazenes: review of comparative pharmacology and antagonist action. Clinical Toxicology, 63, (6), pp. 393-406. https://doi.org/10.1080/15563650.2025.2504133

40.

[News] UNODC Early Warning Advisory on New Psychoactive Substances. [UNODC] May 2025 – Emerging analogues of brorphine. (30 May 2025)